Financing, Equity Capital Markets

ASLAN Pharmaceuticals Pte. Ltd.

05/18
|
$42.2 Million
Piper Sandler served as joint bookrunner for ASLAN Pharmaceuticals Pte. Ltd. on its initial public offering
Sub-Type
IPO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$316.2 Million
ANI
Convertible Offering
Active Bookrunner
$175.0 Million
Day One
PIPE
Joint Placement Agent
Donatelle Plastics, Inc.
Donatelle Plastics, Inc.
Donatelle Plastics, Inc.
Donatelle has been acquired by Dupont
Financial Advisor
$250.0 Million
Pacira BioSciences, Inc.
Pacira BioSciences, Inc.
Senior Note Offering
Passive Bookrunner
$70.0 Million
CereVasc
Bain
Xontogeny
CereVasc, Inc.
CereVasc, Inc. has received a Series B Financing from Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund (PXV)

Financial Advisor
$100.0 Million
Context Therapeutics LLC
Context Therapeutics LLC
PIPE
Sole Placement Agent
$138.0 Million
Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$264.5 Million
Biohaven Ltd.
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$201.2 Million
Nurix Inc.
Nurix Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$100.0 Million
Boundless Bio, Inc.
Boundless Bio, Inc.
Initial Public Offering
Active Bookrunner
$200.0 Million
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.0 Million
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$600.0 Million
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.0 Million
Unicycive
Unicycive Therapeutics
PIPE
Joint Placement Agent
$40.0 Million
Skye Bioscience
Skye Bioscience
PIPE
Sole Placement Agent
$100.0 Million
Ventyx Biosciences
Ventyx Biosciences
PIPE
Joint Placement Agent

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.